Next-Step Treatment for Chronic Back Pain with Sciatica Refractory to Current Therapy

Immediate Medication Adjustments

The American College of Physicians recommends increasing gabapentin to 1200-3600 mg/day in divided doses for therapeutic dosing for radiculopathy, as higher doses are required to achieve small to moderate benefits 1
Duloxetine 30-60 mg daily, titrated to 60 mg, is recommended to target both the neuropathic and inflammatory components of pain, with moderate-quality evidence showing small but meaningful improvements in pain intensity and function 1
The American Academy of Neurology suggests starting duloxetine 30 mg daily for one week, then increasing to 60 mg daily, to address both the neuropathic component of sciatica and any comorbid depression 1
Amitriptyline 10-25 mg at bedtime, titrated to 75-150 mg, is another evidence-based option with moderate efficacy for chronic low back pain, particularly useful for patients who need sedation for sleep disturbance 1

Cyclobenzaprine 5-10 mg at bedtime for 1-2 weeks maximum is recommended for acute pain flares, with the strongest evidence among muscle relaxants for short-term relief 1
Muscle relaxants should not be used beyond 2 weeks, as no evidence supports efficacy in chronic pain and risks of sedation, falls, and cognitive impairment increase with prolonged use 1

Systemic corticosteroids should not be prescribed, as they show no superiority over placebo for low back pain with or without sciatica 1
Benzodiazepines should be avoided entirely, as they are ineffective for radiculopathy and carry substantial risks of abuse, addiction, and tolerance 1
Opioids should be reserved only as a last resort after all other options have failed, given limited evidence for modest short-term effects and significant risks including nausea, constipation, somnolence, and aberrant drug-related behavior 1

Pain intensity and functional status should be reassessed at 2-4 weeks after initiating duloxetine or optimizing gabapentin using a 0-10 scale 1
Duloxetine-specific adverse effects, including nausea, dry mouth, and blood pressure elevation, should be monitored 1
Renal function should be checked before escalating gabapentin doses, as dose adjustment is required in renal impairment, and peripheral edema should be monitored 1
If no meaningful improvement occurs after 4-6 weeks of optimized pharmacotherapy, consider referral for interventional procedures or multidisciplinary pain management, as recommended by the American College of Physicians 2